Evidence map›Paper›PMID 16507994›Full record

ArticleMolecular and cellular biology2006

Involvement of Rac1 in activation of multicomponent Nox1- and Nox3-based NADPH oxidases.

Takehiko Ueyama, Miklós Geiszt, Thomas L Leto

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 104 papers.

0numbers the graph read from it
0cells of the map it votes in
104citing papers in PubMed
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

104 citing papers in PubMed, 224 citations in OpenAlex.

  1. Review
  2. Article
  3. Nox3 expression and function in retinal ganglion cells and Amacrine cells.Cellular and molecular life sciences : CMLS · 2025
    Article
  4. Review
  5. Review
  6. Article
  7. NADPH Oxidase 3: Beyond the Inner Ear.Antioxidants (Basel, Switzerland) · 2024
    Review
  8. Article
  9. Exogenous 8-Hydroxydeoxyguanosine Attenuates PMAntioxidants (Basel, Switzerland) · 2023
    Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Nox3-Derived Superoxide in Cochleae Induces Sensorineural Hearing Loss.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2021
    Article
  18. Cross-Talk between Oxidative Stress and mOxidative medicine and cellular longevity · 2021
    Review
  19. NOX Inhibitors: From Bench to Naxibs to Bedside.Handbook of experimental pharmacology · 2021
    Article
  20. Review

44 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Takehiko UeyamaThe Molecular Defenses Section, Laboratory of Host Defenses, NIH, NIAID, Twinbrook II, Room 203, 12441 Parklawn Dr., Bethesda, MD 20892, USA.
Miklós Geiszt
Thomas L Leto
National Institute of Allergy and Infectious Diseases · USNational Institutes of Health · USSemmelweis University · HU

Funding

NOX family NADPH oxidases: roles in innate immunity and inflammatory diseaseZIAAI000614 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI LETO, THOMAS · 2009 to 2024
$16.2M
STRUCTURE AND FUNCTION OF PHAGOCYTE PROTEINSZ01AI000614 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI LETO, THOMAS · 1991 to 2008
$3.3M
Wellcome Trust
6 · The paper itself

Abstract

Several Nox family NADPH oxidases function as multicomponent enzyme systems. We explored determinants of assembly of the multicomponent oxidases Nox1 and Nox3 and examined the involvement of Rac1 in their regulation. Both enzymes are supported by p47phox and p67phox or homologous regulators called Noxo1 and Noxa1, although Nox3 is less dependent on these cofactors for activity. Plasma membrane targeting of Noxa1 depends on Noxo1, through tail-to-tail interactions between these proteins. Noxa1 can support Nox1 without Noxo1, when targeted to the plasma membrane by fusing membrane-binding sequences from Rac1 (amino acids 183 to 192) to the C terminus of Noxa1. However, membrane targeting of Noxa1 is not sufficient for activation of Nox1. Both the Noxo1-independent and -dependent Nox1 systems involve Rac1, since they are affected by Rac1 mutants or Noxa1 mutants defective in Rac binding or short interfering RNA-mediated Rac1 silencing. Nox1 or Nox3 expression promotes p22phox transport to the plasma membrane, and both oxidases are inhibited by mutations in the p22phox binding sites (SH3 domains) of the Nox organizers (p47phox or Noxo1). Regulation of Nox3 by Rac1 was also evident from the effects of mutant Rac1 or mutant Nox3 activators (p67phox or Noxa1) or Rac1 silencing. In the absence of Nox organizers, the Nox activators (p67phox or Noxa1) colocalize with Rac1 within ruffling membranes, independently of their ability to bind Rac1. Thus, Rac1 regulates both oxidases through the Nox activators, although it does not appear to direct the subcellular localization of these activators.

Indexed as

Adaptor Proteins, Signal TransducingAdaptor Proteins, Vesicular TransportAnimalsBinding SitesCell MembraneCells, CulturedEnzyme ActivationHumansMembrane ProteinsMutationNADPH Oxidase 1NADPH OxidasesPhosphoproteinsProtein Interaction Mappingrac1 GTP-Binding ProteinAdaptor Proteins, Signal TransducingAdaptor Proteins, Vesicular TransportMembrane ProteinsNADPH Oxidase 1NADPH Oxidasesneutrophil cytosol factor 67KNOX1 protein, humanNox3 protein, humanNOXA1 protein, humanNOXO1 protein, humanPhosphoproteinsrac1 GTP-Binding ProteinRAC1 protein, human

Identifiers

PMID16507994
PMCPMC1430270
OpenAlexW2169549805

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.